• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New Microbiol . Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis

tetano

Editor, Senior Moderator
New Microbiol


. 2024 May;47(1):98-102.
Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis

Hui Zheng Hu[SUP] 1 [/SUP], Li Bo Wu[SUP] 1 [/SUP], Qian Liu[SUP] 1 [/SUP], Bin Yan Wu[SUP] 1 [/SUP], Yu Wang[SUP] 2 [/SUP], Rui Ying Wang[SUP] 2 [/SUP]



Affiliations
  • PMID: 38700889
Free article Abstract

The objective of this study was to investigate the risk factors and diagnosis measure of COVID-19-associated pulmonary aspergillosis (CAPA). This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-β-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.

Keywords: CAPA; COVID-19; diagnosis; infections; risk factors.

 
Back
Top Bottom